Eduardo García-Pachón

1.6k total citations
85 papers, 968 citations indexed

About

Eduardo García-Pachón is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Eduardo García-Pachón has authored 85 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 24 papers in Infectious Diseases and 15 papers in Surgery. Recurrent topics in Eduardo García-Pachón's work include Pleural and Pulmonary Diseases (22 papers), Tuberculosis Research and Epidemiology (17 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers). Eduardo García-Pachón is often cited by papers focused on Pleural and Pulmonary Diseases (22 papers), Tuberculosis Research and Epidemiology (17 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers). Eduardo García-Pachón collaborates with scholars based in Spain, Cuba and Romania. Eduardo García-Pachón's co-authors include Isabel Padilla-Navas, Juan Carlos Rodrı́guez, Gloria Royo, Mar Masiá, Santiago Romero, M. Ruiz, Isabel Escribano, Luis Blasco, Javier Bayo and Joaquín López‐Castellanos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hazardous Materials and International Journal of Molecular Sciences.

In The Last Decade

Eduardo García-Pachón

76 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo García-Pachón Spain 18 418 259 242 174 142 85 968
Alastair Watson United Kingdom 17 454 1.1× 86 0.3× 373 1.5× 107 0.6× 24 0.2× 43 1.2k
Digambar Behera India 18 222 0.5× 287 1.1× 213 0.9× 107 0.6× 194 1.4× 75 1.0k
Chaojie Wei China 12 96 0.2× 521 2.0× 95 0.4× 77 0.4× 12 0.1× 23 913
Yi Zuo China 10 172 0.4× 299 1.2× 50 0.2× 42 0.2× 8 0.1× 16 641
Masahiro Aoshima Japan 16 217 0.5× 96 0.4× 554 2.3× 88 0.5× 7 0.0× 83 1.0k
Akira Watanabe Japan 17 138 0.3× 161 0.6× 539 2.2× 94 0.5× 4 0.0× 115 1.1k
Răzvan Petca Romania 16 67 0.2× 43 0.2× 284 1.2× 141 0.8× 24 0.2× 89 774
Guofeng Chen China 16 163 0.4× 335 1.3× 448 1.9× 157 0.9× 5 0.0× 67 1.3k
M Olmer France 17 155 0.4× 86 0.3× 145 0.6× 154 0.9× 5 0.0× 60 841

Countries citing papers authored by Eduardo García-Pachón

Since Specialization
Citations

This map shows the geographic impact of Eduardo García-Pachón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo García-Pachón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo García-Pachón more than expected).

Fields of papers citing papers by Eduardo García-Pachón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo García-Pachón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo García-Pachón. The network helps show where Eduardo García-Pachón may publish in the future.

Co-authorship network of co-authors of Eduardo García-Pachón

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo García-Pachón. A scholar is included among the top collaborators of Eduardo García-Pachón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo García-Pachón. Eduardo García-Pachón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belló-Pérez, Melissa, et al.. (2025). Gene Expression Profiles Reveal Distinct Mechanisms Driving Chronic Obstructive Pulmonary Disease Exacerbations. International Journal of Molecular Sciences. 26(2). 627–627.
2.
García-Pachón, Eduardo, et al.. (2024). Transcriptomic Profiling of Pleural Effusions: Differences in Malignant and Infectious Fluids. Medicina. 60(3). 424–424. 1 indexed citations
3.
García-Pachón, Eduardo, et al.. (2020). Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization. Respiratory Medicine. 171. 106084–106084. 19 indexed citations
4.
García-Pachón, Eduardo, et al.. (2020). Reduction in Hospital Admissions for COPD Exacerbation During the Covid-19 Pandemic. SHILAP Revista de lepidopterología. 2(3). 201–202. 9 indexed citations
5.
García-Pachón, Eduardo, et al.. (2020). Platelet-to-Lymphocyte Ratio and Survival in Malignant Pleural Effusion. Clinical Laboratory. 66(08/2020). 1 indexed citations
6.
García-Pachón, Eduardo, et al.. (2019). Oportunidades perdidas en la detección de la tuberculosis: análisis de las visitas a Urgencias antes del diagnóstico. Revista Clínica Española. 219(7). 390–393. 1 indexed citations
7.
Cremades, Rosa, Juan Carlos Rodrı́guez, Eduardo García-Pachón, et al.. (2011). Interaction between linezolid and Mycobacterium tuberculosis in an experimental in vitro model. Apmis. 119(4-5). 304–308. 4 indexed citations
8.
Cremades, Rosa, Juan Carlos Rodrı́guez, Eduardo García-Pachón, et al.. (2011). Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model. Journal of Antimicrobial Chemotherapy. 66(10). 2281–2283. 25 indexed citations
9.
Flores, Emilio, Juan Carlos Rodrı́guez, Eduardo García-Pachón, et al.. (2009). Real‐time PCR with internal amplification control for detecting tuberculosis: method design and validation. Apmis. 117(8). 592–597. 12 indexed citations
10.
Cremades, Rosa, et al.. (2009). Mycobacterium abscessus from respiratory isolates: activities of drug combinations. Journal of Infection and Chemotherapy. 15(1). 46–48. 24 indexed citations
11.
Escribano, Isabel, et al.. (2007). Importance of the Efflux Pump Systems in the Resistance of <i>Mycobacterium tuberculosis</i> to Fluoroquinolones and Linezolid. Chemotherapy. 53(6). 397–401. 103 indexed citations
12.
Rodrı́guez, Juan Carlos, Eduardo García-Pachón, M. Ruiz, & Gloria Royo. (2006). Drug Susceptibility of the Mycobacterium Genus: In Vitro Tests and Clinical Implications. Current Clinical Pharmacology. 1(3). 277–289. 5 indexed citations
13.
García-Pachón, Eduardo, et al.. (2005). Apolipoproteína A1 y apolipoproteína B en los derrames pleurales. Revista Clínica Española. 205(8). 363–366. 1 indexed citations
14.
García-Pachón, Eduardo, et al.. (2005). C-Reactive Protein in Lymphocytic Pleural Effusions: A Diagnostic Aid in Tuberculous Pleuritis. Respiration. 72(5). 486–489. 18 indexed citations
15.
García-Pachón, Eduardo, et al.. (2005). Litoptisis crónica idiopática. Archivos de Bronconeumología. 41(8). 468–470. 2 indexed citations
16.
García-Pachón, Eduardo, et al.. (2005). Movimiento costal paradójico durante la inspiración (signo de Hoover) en pacientes hospitalizados por disnea. Revista Clínica Española. 205(3). 113–115. 3 indexed citations
17.
García-Pachón, Eduardo, et al.. (1999). Pseudochylothorax in pleural effusion due to coronary artery bypass surgery. European Respiratory Journal. 13(6). 1487–1488. 6 indexed citations
18.
García-Pachón, Eduardo, et al.. (1997). Elevated Level of Carcinoembryonic Antigen in Nonmalignant Pleural Effusions. CHEST Journal. 111(3). 643–647. 47 indexed citations
19.
Martí‐Fàbregas, Joan, et al.. (1996). Forced vital capacity deterioration in amyotrophic lateral sclerosis has an inflexion point. European Journal of Neurology. 3(1). 40–43. 7 indexed citations
20.
García-Pachón, Eduardo, et al.. (1994). Encuesta sobre los conocimientos básicos de los enfermos respiratorios crónicos. Archivos de Bronconeumología. 30(3). 163–165. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026